VV
Versant Venture Management, LLC
13F filer · CIK 0001560009Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$163MU.S. long equity reported on 13F
Positions80 new · 0 closed
Net flow last quarter-$11.9MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 12, 20268 positions | |||||
| $77M | 47.34% | 3.73% | Not reported | Q4 2024 | |
| $29.8M | 18.33% | 6.74% | Not reported | Q1 2026 | |
| $22M | 13.55% | 1.56% | -35.0% | Q2 2025 | |
| $15.1M | 9.28% | 8.46% | Not reported | Q3 2025 | |
| $8.89M | 5.47% | 2.35% | Not reported | Q2 2024 | |
| $8.12M | 4.99% | 0.15% | Not reported | Q2 2018 | |
| $1.39M | 0.86% | 5.71% | Not reported | Q1 2024 | |
| $299K | 0.18% | 1.69% | Not reported | Q4 2024 | |
| Q1 2026Reported May 5, 20268 positions | |||||
| $52.3M | 37.00% | 3.77% | -27.4% | Q4 2024 | |
| $27.5M | 19.44% | 6.76% | New | Q1 2026 | |
| $24.3M | 17.19% | 8.47% | Not reported | Q3 2025 | |
| $21.4M | 15.16% | 3.09% | Not reported | Q2 2025 | |
| $7.09M | 5.01% | 2.35% | Not reported | Q2 2024 | |
| $7.08M | 5.01% | 0.15% | Not reported | Q2 2018 | |
| $1.23M | 0.87% | 5.72% | Not reported | Q1 2024 | |
| $442K | 0.31% | 1.88% | Not reported | Q4 2024 | |
| Q4 2025Reported Feb 12, 20267 positions | |||||
| $68.7M | 45.49% | 6.69% | -22.5% | Q4 2024 | |
| $42.5M | 28.14% | 8.48% | Not reported | Q3 2025 | |
| $23.5M | 15.59% | 3.09% | Not reported | Q2 2025 | |
| $7.8M | 5.17% | 0.16% | Not reported | Q2 2018 | |
| $6.2M | 4.11% | 2.35% | Not reported | Q2 2024 | |
| $1.51M | 1.00% | 6.02% | Not reported | Q1 2024 | |
| $774K | 0.51% | 5.48% | Not reported | Q4 2024 | |
| Q3 2025Reported Nov 10, 20259 positions | |||||
| $124M | 58.25% | 9.29% | New | Q3 2025 | |
| $41.9M | 19.72% | 9.15% | Not reported | Q4 2024 | |
| $13.2M | 6.20% | 4.68% | Not reported | Q2 2025 | |
| $9.65M | 4.54% | 0.16% | -70.2% | Q2 2018 | |
| $7.89M | 3.71% | 6.48% | Not reported | Q1 2024 | |
| $6.38M | 3.00% | 1.94% | Not reported | Q2 2024 | |
| RTRPTXRepare Therapeutics Inc. | $4.66M | 2.19% | 6.16% | Not reported | Q2 2023 |
| $2.77M | 1.31% | 6.08% | Not reported | Q4 2024 | |
| ABADVMAdverum Biotechnologies, Inc. | $2.3M | 1.08% | 2.42% | Not reported | Q1 2020 |
Premium opens every quarter this fund has filed